Alpharma Inactive 10-Q2004 Q2 Quarterly report

Filed: 5 Aug 04, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: actuarial, adequacy, adequate, alia, APBO, Aquatic, attestation, build, care, case, channel, chosen, civil, criminal, critical, customary, discrete, disgorgement, Disposal, duty, endeavor, enrichment, exceed, experienced, faith, fine, fish, Florida, framework, functioning, furthe, guilty, headquartered, hearing, immunizing, inability, intend, inter, jurisdiction, Kentucky, Kroner, le, life, Medi, Metf, nature, Nevada, nineteen, Norway, ormin, Oslo, payab, poultry, prescribed, program, prohibited, proof, question, region, relaxed, salmon, Se, Senor, SFO, shelf, sought, Sta, statute, statutory, stayed, subpoena, Supreme, tement, thousand, treble, twelve, UK, unjust, upcoming, variety

Removed: accelerated, check, claim, commencement, commitment, conclude, conform, defending, determine, extent, external, filer, guidance, individual, insurance, liquidity, mark, marketed, moved, occurred, Page, par, past, policy, preceding, preparing, pressure, recently, reconsideration, recovery, registrant, requirement, restrictive, resulting, shorter, similar, structure, understanding, WASHINGTON

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Alpharma similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Alpharma Inc. (the "Company") on Form 10Q for the period ending June 30, 2004 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies, pursuant to 18 U.S.C. 1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Dated: August 5, 2004

/s/ Ingrid Wiik
Ingrid Wiik
President and Chief Executive Officer

Dated: August 5, 2004

/s/ Matthew Farrell
Matthew Farrell
Chief Financial Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.